About ROSGEM
The Russian Society of Gynecological Endocrinology and Menopause (ROSGEM) is a Society of specialists engaged in practical, teaching and research activities in the field of gynecological endocrinology and menopause. ROSGEM coordinates the scientific and practical activities of the members of the Society in the field of gynecological endocrinology and menopause in order to disseminate the up-to-date knowledge in the field of health of young and aging population (in Russia there are more than 42 million women over the age of 40) by on-site and online training.
The Russian Society of Gynecological Endocrinology and Menopause is the only society in the field of gynecological endocrinology and menopause with the status of an all-Russian society, which includes more than 17,000 Russian-speaking members from different countries including Belarus, Kazakhstan and other countries of the CIS.
The Russian Society of Gynecological Endocrinology and Menopause (ROSGEM, former name – Russian Menopause Society) was established in 1996 by professors Vera Smetnik and Vera Balan on the basis of the department of Gynecological Endocrinology of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov of the Ministry of Healthcare of the Russian Federation (Moscow). The membership is free.
Contact Email: info@rosgem.org
Website: www.rosgem.org
Upcoming Events
Gynecological Endocrinology and Menopause: Decision-Making Algorithms
September 14-16, 2023
Executive
President
Antonina Smetnik
MD, Ph.D., Head of the Department of Gynecological Endocrinology of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov of the Ministry of Healthcare of the Russian Federation (Moscow).
Member of the EMAS Advisory Board (Board Member of the EMAS, 2021-2023).
Member of the Editorial Board of the GREM Journal.
Antonina and the Department of Gynecological Endocrinology with ROSGEM are setting up the first Menopause Clinic in Russia (Moscow).
Vice President
Elena Ermakova
Senior Researcher of the Department of Gynecological Endocrinology of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov of the Ministry of Healthcare of the Russian Federation (Moscow)
General Secretary
Gyuzyal Tabeeva
Senior Researcher of the Department of Gynecological Endocrinology of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov of the Ministry of Healthcare of the Russian Federation (Moscow)
Honorary President
Vera Balan
Doctor of Medical Sciences,
Professor, Head outpatient department of the Moscow Regional Healthcare Institution Research Institute of Obstetrics and Gynecology
Clinical Updates
- Ovulation disorders: classification of the International Federation of Obstetricians and Gynecologists (FIGO)
- Eligibility Criteria for Menopausal Hormone Therapy (MHT): Position Statement of the Consortium of Scientific Societies on the Use of MHT in Women with Various Diseases
- European Society of Human Reproduction and Embryology (ESHRE) Guideline: Endometriosis
- Menopause, well-being and health: principles of patient management proposed by the European Society for Menopause and Andropause
- Topical estrogens and non-hormonal agents for the treatment of postmenopausal vulvovaginal atrophy: European Menopause and Andropause Society (EMAS) clinical guidelines
- Postmenopausal Sexual Well-Being – IMS Information Booklet
Educational resources
- Commentary of the Russian Menopause Association on the meta-analysis of epidemiological data “Type and duration of menopausal hormone therapy and the risk of breast cancer”
- Can testosterone really help us?
- Bone Health Update: International Menopause Society White Paper 2021
- Premature ovarian failure: answers to your questions
Menopause Specialists
Database of specialists in the field of gynecological endocrinology and menopause in Russia
News
- Endometriosis and gut microbiota
- Clinical efficacy of intraovarian administration of mesenchymal stromal cells of menstrual blood in women with premature ovarian insufficiency
- Estimated risk of type 2 diabetes mellitus in normal-weight women with polycystic ovary syndrome
- Effect of Hormone Therapy on Bone Mineral Density in Women With Premature Ovarian Failure
- October 18 is World Menopause Day! Joint activity with Medscape
Join ROSGEM
Click here for the online application: Sign up (rosgem.org)
